Ontario’s COVID-19 Genomics Rapid Response Coalition
About
To accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario and to help expedite patient genome sequencing through a coordinated approach bringing together all of the province’s genomics resources and capacity to enable timely and comprehensive genomic analysis.
Genomics
Infrastructure
Standardized Sequencing Methodologies
Bioinformatics
Infrastructure
Data Management & Sharing
The ON-CoV Coalition is designed to provide for method standardization and coordination of:
1
Collecting Patient Samples and Metadata
2
Sequencing
3
Data Curation and Management
4
Epidemiological Studies
This work will expedite real-time testing and reporting to inform public health and public policy, help manage and overcome the ongoing COVID-19 crisis and ensure scalability for Ontario’s future pandemics preparedness.
Why Genomics?
Genomic technologies are the foundation for the solutions necessary to combat the ongoing COVID-19
pandemic. Ontario’s world-leading expertise in genomics, bioinformatics, genomics epidemiology, and artificial intelligence, can expedite Ontario’s response to COVID-19.
The results reported by the Coalition will inform vaccine and therapeutic development.
Why Ontario Genomics?
Over the past 20 years, Ontario Genomics, together with the Ontario Government, Genome Canada, and academic, clinical and industry partners, has built a world-leading genomics ecosystem in Ontario with over $2.7B in funding leveraged for research, translation and the establishment of genomic technology platforms.
Ontario Genomics is well-positioned to provide and promote:
COLLABORATION
LEADERSHIP
EXPERTISE
Members
ONCoV Genomics Coalition Steering Committee
-
Dr. Samira Mubareka, Sunnybrook Health Sciences/University of Toronto
-
Dr. Herveen Sachdeva, Toronto Public Health
-
Dr. Sarah Wootton, University of Guelph
ONCoV Genomics Coalition Members
Aaron Campigotto
University of Toronto
Bettina Hamelin
Ontario Genomics
Samira Mubareka
Sunnybrook Health Sciences / University of Toronto
Danielle Brabant-Kirwan
Health Sciences North
Robyn Lee
Dalla Lana School of Public Health, University of Toronto
Letitia Nadalin Penno
Canadore College
Nahuel Fittipaldi
Public Health Ontario
Andrew G. McArthur
McMaster University
Marc Fiume
DNAstack
Allison McGeer
Sinai Health Systems
Prameet M. Sheth
Kingston Health Sciences Centre / Queen’s University
Jared Simpson
Ontario Institute for Cancer Research
Michael Szego
Unity Health Toronto / University of Toronto
David Villeneuve
Canadore College
Bo Wang
Peter Munk Cardiac Centre, UHN / University of Toronto
Sarah Wootton
University of Guelph
We are proactively working with the research community, partner genome centres, and governments to accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario. Learn more and stay up-to-date about our COVID-19 programs and important resources.
Partners
Contact
A closer look at Canada's homegrown COVID-19 vaccine candidates
Scientists across Canada are using a range of technologies, from more traditional protein subunit vaccines to newer technologies such as replicating viral vector and DNA vaccines to produce immunity against SARS-CoV-2.
McMaster researchers awarded $1.475M to further investigate COVID-19
A team of McMaster researchers has been awarded $1.475M from the federal government to further investigate COVID-19. Overall, the fund will provide close to $28M for 79 projects at 52 universities, research hospitals, colleges, polytechnics and Cégeps across Canada
Consortium Secures $5M to Expand Genomics Platform for COVID Research
A national consortium led by DNAstack will expand development of a software platform for genomics and health data and apply it to COVID-19. The $5.1M project, called COVID Cloud, is co-funded by Canada’s Digital Technology Supercluster and aims to increase Canada’s capacity to harness exponentially growing volumes of genomics and biomedical data to advance precision health.
December 1, 2020
November 6, 2020
October 19, 2020